FDA Clearance Tracker · P190009-S009
OPRA Implant System
Last checked: Nov 20, 2026Latest source record: Aug 14, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Aug 14, 2025
Approved
Time to decision
21 days
Received Jul 24, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P190009-S009
- Device name
- OPRA Implant System
- Applicant
- Integrum AB
- Applicant location
- MöLndal
- Received
- Jul 24, 2025
- Decided
- Aug 14, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P190009
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P190009
Source documents
Other decisions for Integrum AB
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P190009 · Decided Dec 18, 2020 · 623 days after receipt
Device type: Osseoanchored prostheses for the rehabilitation of transfemoral amputees (PJY) · Orthopedic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.